Putting the Spinal Cord Together Again  by Behar, Oded et al.
Neuron, Vol. 26, 291±293, May, 2000, Copyright ª 2000 by Cell Press
Putting the Spinal Cord Minireview
Together Again
much remains to be learned. We are not, unfortunately,
even at the beginning of applying this knowledge to the
clinic. This remains an enormously daunting problem,
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and Clifford J. Woolf*
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one whose complexity cannot be minimized, and whichDepartment of Anesthesia
needs to be confronted with a realistic sense not onlyMassachusetts General Hospital and
of what is needed but also what is possible. ClinicalHarvard Medical School
intervention clearly will be contingent on our under-Charlestown, Massachusetts 02129
standing the neurobiology of regeneration.
Regeneration Failure
Successful regeneration depends upon the ability ofHumpty Dumpty sat on a wall, Humpty Dumpty had a
injured axons to survive, regrow, and reconnect withgreat fall, all the King's horses and all the King's men
their original targets, processes integral to normal devel-couldn't put Humpty together again.
opment. Why then is the regenerative response abortive
Spinal Cord Injury in the adult mammalian CNS? There are three explana-
In view of the anatomical arrangement of its ascending tions: death of the injured neurons, an inability of differ-
and descending fiber tracts, even local limited injury to entiated adult neurons to initiate or maintain axonal
the spinal cord typically has devastating consequences. growth, and a lack of an environment permissive for
Communication between that part of the body below such growth (Figure 1).
the level of injury and the brain is disturbed, resulting The inability of the CNS environment to support
in permanent para- or quadriplegia and an equivalent growth appears to be due to both the presence of inhibi-
loss of sensation. These motor and sensory deficits are tory and a lack of growth-promoting signals. There are
usually accompanied by positive symptoms, including three sources of such signals; on cells, in the extracellu-
pain and exaggerated motor and autonomic reflexes. lar matrix, and diffusible molecules. One major source
Treatment for traumatic spinal cord injury has until of inhibition is myelin. Schwab and colleagues demon-
now only had two aims, both conservative. The first at strated some years ago that a monoclonal antibody gen-
the time of injury is to prevent further damage by high- erated against central myelin, IN-1, improved neuronal
dose steroids and, where appropriate, stabilizing the regeneration (reviewed by Tatagiba et al., 1997). Since
vertebral column and removing compressive tumors and then, myelin-associated glycoprotein (MAG) has been
any source of infection. The second is rehabilitative, shown to be a myelin-associated growth-inhibitory mol-
ecule (reviewed by Fawcett and Asher, 1999). Recently,teaching the patient and their family to live with this
a major achievement has been the cloning and expres-disability by optimizing intact function and reducing
sion of a novel protein, Nogo-A, that is the specific targetproblems like poor ventilation, bedsores, bladder infec-
for IN-1's action (Chen et al., 2000; GrandPre et al., 2000;tions, joint fixation, and muscle wastage.
Prinjha et al., 2000). Only a small portion of Nogo-A isWhat are the realistic prospects for a much more am-
expressed on the surface (GrandPre et al., 2000), andbitious treatment objective aimed at promoting regener-
the cells may need to be damaged for significant quanti-ation and restoration of lost function? Can we put the
ties of Nogo-A to be released. Understanding the mech-injured spinal cord together again? That we can even
anism of action of Nogo-A and MAG requires the eluci-begin to contemplate the feasibility of promoting regen-
dation of their receptors, and this is eagerly awaited. Ineration in the spinal cord is a measure of the almost
addition to Nogo-A and MAG, it is likely that other my-explosive success that has been achieved recently in
elin-related molecules inhibit regeneration. When theelucidating how neuronal growth occurs in development
animals' own immune system is engaged to produceand why it fails in the adult CNS. This success can be
antibodies against all myelin-associated molecules byattributed to a multiplicity of approaches in diverse fields
means of autoimmunization to myelin, a regenerativeincluding genetics, biochemistry, molecular and cellular
response apparently greater than that produced usingbiology, and physiology. Genetic approaches in Dro-
specific antibodies occurs (Huang et al., 1999). However,sophila and C. elegans together with biochemical and
even this approach only leads to limited regeneration,cellular approaches in mammals have, for example, re-
suggesting that other factors are involved in preventingvealed a large number of molecules that potentially have
axonal regeneration.a role in axon guidance in development and in aborting
One potential growth obstacle is the glial scar tissuegrowth in the adult. Other approaches that have an in-
that forms at the site of injury. Using a microtransplanta-creasing bearing on our growing understanding of CNS
tion technique avoiding glial scarring and damage toregeneration include embryonic and adult stem cell biol-
myelin, Davies and colleagues (Davies et al., 1997) dem-ogy, the analysis of intracellular signal transduction cas-
onstrated that dissociated adult dorsal root ganglioncades, and the biology of cell death. The progress
(DRG) neurons injected into the CNS grow axons for
achieved, although very promising, is really just the be-
long distances on the outer surface of the myelin leaflet.
ginning of a real understanding of regeneration, and
Intact myelin is then apparently permissive for growth,
and only damaged or exposed myelin appears to inhibit
growth. Even when these axons encounter tracts under-* To whom correspondence should be addressed (e-mail: woolf.
clifford@mgh.harvard.edu). going Wallerian degeneration (Davies et al., 1999), they
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into the spinal cord only after intrathecal administration
of neurotrophins (Ramer et al., 2000). A different ap-
proach to overcome the negative CNS environment has
been to use cell and tissue transplants to provide a
physical growth-promoting substrate. Such grafts have
included peripheral nerves, Schwann cells, and embry-
onic stem cells (McDonald et al., 1999). Recently, Ra-
mon-Cueto and colleagues using olfactory ensheathing
glial cell (OEG) transplants into the injured spinal cord
(Ramon-Cueto et al., 2000) substantially improved re-
covery of function.
In addition to the environment, the state of the injured
neuron is critical. One imperative is to prevent cell death;
if this has occurred, stem cell transplants offer the possi-
bility of replacing lost neurons (McDonald et al., 1999).
Another is to ensure that the injured neuron is capable
of growth. Preinjury to the peripheral branch of DRG
neurons, which induces an increase in intrinsic growth
capacity, has recently been shown to significantly im-
prove the regenerative response of the central branch
in the dorsal columns after spinal cord injury (Neumann
and Woolf, 1999). For a presently unknown reason, injur-
ing one axon of sensory neurons (the peripheral) and
not another (the central) switches the cell into an actively
Figure 1. Signals that Influence Regeneration after CNS Axonal growing state such that it can grow into environments
Injury normally hostile for regeneration. We need to find out
Regeneration: neurotrophins and G1 protein inhibitors overcome why and replicate this without injuring the neuron. Two
MAG and oligodendrocyte myelin inhibition by increasing cAMP in
other studies have also shown that increasing the intrin-the growth cone, C3 toxin inactivates Rho GTPase promoting axon
sic growth state improves the regenerative response.regeneration, inosine increases intrinsic growth, and antisera
against myelin neutralize its inhibitory actions. Inhibition of regener- Inosine, acting via a direct intraneuronal mechanism,
ation: negative signals include the glial scar, reactive astrocytes, improves the growth response of intact neurons (collat-
components of the extracellular matrix, Nogo-A, and MAG. eral sprouting) after spinal cord injury (Benowitz et al.,
1999), while inhibition of Rho, a small G-coupled protein
involved in signaling to the growth cone cytoskeleton,
continue to grow robustly; one explanation may be that
improves regeneration of the optic nerve (Lehmann et
they do not directly contact the myelin debris, while
al., 1999).
another may be that they do not express the receptors
New insights into signal transduction pathways in the
for myelin inhibitors. However, when the DRG axons
developing growth cone suggest that repulsive signalsencounter an established scar, their growth halts. The
can be inverted into positive cues (Song and Poo, 1999).molecules responsible are unknown. Candidates in-
One indication of this is that conditioning stimuli suchclude developmental growth cone inhibitory guidance
as neurotrophins that raise intracellular cAMP invert thecues. Two such molecules, semaphorin 3A (Pasterkamp
response to MAG (Cai et al., 1999). Therefore, targetinget al., 1999) and EphB3 (Miranda et al., 1999), are ex-
the intracellular signal transduction cascade or activat-pressed at the site of CNS injury, and semaphorin 3A is
ing enzymes downstream from such cascades may berepellent to adult DRG neuron growth cones (Reza et
a useful therapeutic approach to promote regenerational., 1999). Other contributors may be extracellular matrix
without having to change the local environment.molecules like the proteoglycans phosphacan, versican,
Most recent studies in the regeneration field tend tobrevican, and neurocan and some adhesion molecules
emphasize the increased axonal growth that can besuch as tenascin-R, acting as a growth cone glue (re-
achieved by different manipulations. Axonal growth, al-viewed by Fawcett and Asher, 1999). It is interesting
though necessary, is not by itself sufficient for functionalthat if neurons are primed for regeneration at the time
recovery; however, retrieval of the appropriate path-of injury (Neumann and Woolf, 1999) or if myelin inhibi-
ways, target recognition, orderly reinnervation, and re-tors are neutralized immediately after injury (Huang et
establishment of functioning synapses are essential.al., 1999), axons regenerate before the glial scar forms,
These are areas where we know considerably less aboutand the scar forms around the regenerated axons.
the signal determinants, although developmental stud-Positive signals in the environment can augment re-
ies are likely to help substantially. A risk inherent ingeneration. The addition of neurotrophic factors, for ex-
promoting growth without controlling target connec-ample, improves CNS regeneration, which may be ac-
tions is that maladaptive function may develop. Severalcomplished by ensuring survival, acting as positive
neurological conditions, including neuropathic pain, aregrowth cues, as well as priming the injured cells to pro-
actually an expression of such maladaptive structuralduce the molecular machinery necessary for growth.
plasticity. We do not want axonal growth at any price;McMahon and colleagues have recently shown that
adult DRG axons grow across the dorsal root entry zone targeted growth is required.
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synaptic contact. Although cautious optimism is begin-Table 1. Strategies for Promoting Spinal Cord Regeneration
ning to be appropriate, there are great scientific chal-
Objectives
lenges that still need to be met before it is time to focus
Prevent secondary damage on or initiate clinical therapies.
neuronal death/atrophy
Prevent scar formation Selected Reading
glial cell reaction/extracellular matrix formation
Optimize environment for axonal growth Benowitz, L.I., Goldberg, D.E., Madsen, J.R., Soni, D., and Irwin, N.
decrease inhibitory environment (1999). Proc. Natl. Acad. Sci. USA 96, 13486±13490.
provide permissive environment Cai, D., Shen, Y., De Bellard, M., Tang, S., and Filbin, M.T. (1999).
Optimize neuronal response Neuron 22, 89±101.
increase growth response
Chen, M.S., Huber, A.B., van der Haar, M.E., Frank, M., Schnell, L.,decrease response to inhibitory influences
Spillmann, A.A., Christ, F., and Schwab, M.E. (2000). Nature 403,provide axon guidance cues
434±439.ensure contact with appropriate target neuron
Davies, S.J.A., Fitch, M.T., Memberg, S.P., Hall, A.K., Raisman, G.,promote synaptic differentiation
and Silver, J. (1997). Nature 390, 680±683.prevent maladaptive connectivity
Davies, S.J.A., Goucher, D.R., Doller, C., and Silver, J. (1999). J.Techniques
Neurosci. 19, 5810±5822.
Suppress acute injury response Fawcett, J.W., and Asher, R.A. (1999). Brain Res. Bull. 49, 377±391.
anti-inflammatory agentsÐmethyl prednisolone GrandPre, T., Nakamura, F., Vartanian, T., and Strittmatter, S.M.
Prevent injury-induced neuronal loss (2000). Nature 403, 439±444.
neuroprotectionÐglutamate receptor antagonists/ion
Huang, D.W., McKerracher, L., Braun, P.E., and David, S. (1999).channel blockers/growth factors
Neuron 24, 639±647.Prevent scar formation
Lehmann, M., Fournier, A., Selles-Navarro, I., Dergham, P., Sebok,target glial cell reaction
A., Leclerc, N., Tigyi, G., and McKerracher, L. (1999). J. Neurosci.Suppress inhibitory influences in the environment
19, 7537±7547.vaccination against myelin proteins
neutralizing antibodies/receptor bodies targeted at inhibitory McDonald, J.W., Liu, X.Z., Qu, Y., Liu, S., Mickey, S.K., Turetsky,
proteins (Nogo, etc.) D., Gottlieb, D.I., and Choi, D.W. (1999). Nat. Med. 5, 1410±1412.
receptor antagonists Miranda, J.D., White, L.A., Marcillo, A.E., Willson, C.A., Jagid, J.,
abort growth cone collapseÐintracellular signal transduction modifiers and Whittemore, S.R. (1999). Exp. Neurol. 156, 218±222.
Provide permissive environment
Neumann, S., and Woolf, C.J. (1999). Neuron 23, 83±91.supporting cell bridgesÐperipheral nerve grafts
Pasterkamp, R.J., Giger, R.J., Ruitenberg, M.J., Holtmaat, A.J.G.D.,embryonic tissue/stem cell grafts
De Wit, J., De Winter, F., and Verhaagen, J. (1999). Mol. Cell. Neu-Schwann cells/olfactory ensheathing glia
rosci. 13, 143±166.acellular matrix conduits
Target neuron Prinjha, R., Moore, S.E., Vinson, M., Blake, S., Morrow, R., Christie,
G., Michalovich, D., Simmons, D.L., and Walsh, F.S. (2000). Natureadminister molecules that increase intrinsic growth capacity
activate growth cone signal transduction cascades 403, 383±384.
potassium channel blockersÐoptimizing conduction Ramer, M.S., Priestley, J.V., and McMahon, S.B. (2000). Nature 403,
replace neuronsÐstem cell transplants 312±316.
Ensure pathway retrieval, target recognition, and orderly reinnervation Ramon-Cueto, A., Cordero, M.I., Santos-Benito, F.F., and Avila, J.
provide guidance cues and ensure specific target recognition (2000). Neuron 25, 425±435.
Reza, J.N., Gavazzi, I., and Cohen, J. (1999). Mol. Cell. Neurosci.
14, 317±326.
Clinical ApplicationÐThe Challenge Song, H.J., and Poo, M.-M. (1999). Curr. Opin. Neurobiol. 9, 355±363.
Demonstration of successful spinal cord regeneration
Tatagiba, M., Brosamle, C., and Schwab, M.E. (1997). Neurosurgery
in experimental models is nontrivial. It requires unambig- 40, 541±547.
uous proof that injured and not neighboring intact neu-
rons have grown, that novel functional synapses have
been established, and that these are responsible for any
improvement in functional recovery and that any such
recovery is not accompanied by maladaptive function.
Very few studies fulfill all these criteria, and conse-
quently there is often uncertainty as to how much regen-
eration has occurred and its functional significance. The
rate of recent progress indicates, though, that we are
likely to learn soon why regeneration fails in the adult
CNS and may be able to devise technical approaches
to use this knowledge to further enhance regeneration.
The therapeutic strategies necessary to achieve suc-
cessful spinal cord regeneration are shown in Table 1.
Given the complexity and diverse response of the CNS
to injury, it is extremely unlikely that a single approach
will suffice. Multiple interventions will be required at
coordinated times to initiate, maintain, and guide regen-
eration of injured neurons from their site of injury to the
appropriate target neurons, and to reestablish functional
